Open access · OA
via Europe PMC
Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
Cancers · 2026
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
J, B., & A., C. (2026). Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities. <em>Cancers</em>. https://europepmc.org/article/PMC/PMC13664522
Vancouver
J B, A. C. Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities. Cancers. 2026.
BibTeX
@article{blanco2026Therap,
title = {Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities},
author = {Blanco J and Carnero A.},
journal = {Cancers},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature reviews. Cancer 2022
Open access · OA
Exploiting senescence for the treatment of cancer
Nature reviews. Cancer 2018
Preprint · OA
Mechanisms of cancer resistance in long-lived mammals
Nature Reviews Clinical Oncology 2022
Open access · OA
Senescence and cancer — role and therapeutic opportunities
Frontiers in cellular neuroscience
Open access · OA
Cellular senescence in brain aging and neurodegeneration: from molecular mechanisms to translational opportunities
Nature Reviews Molecular Cell Biology 2020
Preprint · OA
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Nature Metabolism 2021
Open access · OA